1
DANNINGER MEDICAL TECHNOLOGY, INC. AND SUBSIDIARIES
EXHIBIT 11
COMPUTATION OF NET INCOME PER SHARE
Years ended December 31,
-------------------------------------
1995 1994 1993
---- ---- ----
Weighted average number of common shares outstanding 4,661,332 4,475,954 4,420,312
Shares issuable pursuant to employee stock option plans
and stock warrants, less shares assumed repurchased at
the average market share (1) 219,464 (1)
---------- ---------- ----------
Weighted average shares outstanding, including common
stock equivalents 4,661,332 4,695,418 4,420,312
========== ========== ==========
Net income (loss) $ (358,941) $ 81,388 $ (744,262)
========== ========== ==========
Net income (loss) per share $ (.08) $ .02 $ (.18)
========== ========== ==========
Note: The application of the higher of quarter-end or year-end market prices
in calculating fully-diluted earnings per share does not result in material
dilution to the reported earnings per share amounts.
(1) Shares issuable under these common stock equivalents are anti-dilutive and
therefore have been excluded from this schedule.